Keith M Hamel

Years Active: 2020-2020
Publications (10 Years): 1

AbbVie Inc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AbbVie Inc Jan 11 2015

United States

Principal Research Scientist :: Oncology

Publications

Frederick J Kohlhapp, Dipica Haribhai, Rebecca Mathew, Ryan Duggan, Paul A Ellis, Rui Wang, Elisabeth A Lasater, Yan Shi, Nimita Dave, Jacob J Riehm, Valerie A Robinson, An D Do, Yijin Li, Christine J Orr, Deepak Sampath, Aparna Raval, Mark Merchant, Anahita Bhathena, Ahmed Hamed Salem, Keith M Hamel, Joel D Leverson, Cherrie Donawho, William N Pappano, Tamar Uziel
Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade. Cancer discovery 11 (1) (2020)

Keith M Hamel.css-eqlu8i{font-size:small;padding-left:4px;}